ENOV DJO Global: Utang-utang marang kapitalisasi buku

Logo korporat perusahaan Enovis Corp (ENOV)

The price history of Enovis Corporation (ENOV) reflects the dynamics of an asset whose pricing power is constrained by the influence of US group purchasing organizations, with the current indicator standing at 0.88. The business relies on capturing the high-tech surgery niche through acquisitions and expansion into Western markets. Simultaneously, the company is resisting pressure from corporate behemoths seeking to displace mid-sized manufacturers by acquiring promising startups.

Enovis Inc. - Utang-utang marang aset resik ENOV (periode 28.04.2023 - 29.10.2026)
Produk asli Enovis Corp

This indicator measures the company's reliance on borrowed funds relative to its equity, allowing for an assessment of financial stability and the risk of debt load volatility. By analyzing the chart of the total debt-to-book capitalization ratio, an investor can gauge the funding reliability of Enovis Corporation (ENOV) high-tech developments in biomechanics and robotics, which is critical for retaining top talent within the stable healthcare sector.

Pesaing langsung

Utang-utang marang kapitalisasi buku BSX (Boston Scientific)|edwards.com (EW) - Utang-utang marang nilai buku|ResMed - Utang-utang marang kapitalisasi buku|Insulet Corp (PODD) - Utang marang nilai buku|ZBH: Utang-utang marang kapitalisasi buku|COO - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku globusmedical.com|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku ATEC (Alphatec Holdings)|Utang-utang marang kapitalisasi buku AORT (Artivion Inc)|Utang-utang marang aset resik Integra LifeSciences Inc. (IART)|ESTA: Utang marang nilai buku|Rasio utang-utang marang kapitalisasi buku BBNX|IRMD: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Embecta Corp (EMBC)|TNDM (Tandem Diabetes) - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku AXGN (Axogen Surgical)|Utang marang nilai buku SIBN (SI-BONE, Inc.)|OFIX (orthofix.com) - Rasio utang marang aset resik|Rasio utang marang kapitalisasi buku Bioventus BVS|KIDS - Utang marang nilai buku|Treace Medical - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Strata Medical|CARL: Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku RXST|CLPT (ClearPoint Neuro Inc.) - Utang-utang marang kapitalisasi buku|Stereotaxis Inc (STXS) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku STIM|Utang marang nilai buku Sight Sciences Inc SGHT|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Utang-utang marang kapitalisasi buku Anika Therapeutics Inc. ANIK|NSPR - Rasio utang marang kapitalisasi buku|ZJYL: Rasio utang marang kapitalisasi buku|VANI (vivani.com) - Utang marang nilai buku|Xtant Medical - Rasio utang marang aset resik|NMTC (NeuroOne Medical Technologies) - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Modular Med MODD|Rasio utang marang kapitalisasi buku Myomo (MYO)|Envoy Medical Inc. (COCH) - Utang marang aset resik|Vivos Therapeutics, Inc - Utang marang nilai buku|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|SINTX Technologies - Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik tenonmed.com TNON|Lifeward (LFWD) - Rasio utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku AMIX (Autonomix Medical)|Rasio utang marang kapitalisasi buku INVO Bioscience, Inc.|Utang marang nilai buku Bone Biologics Inc (BBLG)|Utang-utang marang kapitalisasi buku AXNX|BIOL - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Dynatronics DYNT|FNA: Rasio utang marang nilai buku|INVO: Utang marang nilai buku